Discovery and Development of HGR4113 as a Novel Antidiabetes Oral Agent
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1158-p
Abstract: HGR4113 is a novel compound that was discovered by Glaceum Inc. through a Quantitative Structure-Activity Relationship (QSAR) study on Glabridin and its derivatives. HGR4113 showed competitive antihyperglycemic effects in db/db mice without any adverse event… read more here.
Keywords: self glaceum; hgr4113 novel; hgr4113; employee self ... See more keywords